Harmony Biosciences Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation
Harmony Biosciences Holdings Inc HRMY
$29.83
▼ -0.86%
($-0.26)
Open
$30.13
Prev Close
$30.09
Day Range
$29.67 – $30.48
52W Range
$25.52 – $40.87
Market Cap
$1.73B
P/E (TTM)
11.86
Beta
0.98
EPS (TTM)
$2.49
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-08-19 |
| Shares Out. | 57,870,000 |
| Website | harmonybiosciences.com/ ↗ |
| Phone | 13026587581 |
Harmony Biosciences Holdings Inc is a publicly traded company under the ticker symbol HRMY on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-05-01)
📰 Latest News for HRMY
Harmony Biosciences Holdings (HRMY) Valuation After Q1 2026 Earnings Miss And Profitability Concerns
Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?
Truist Securities Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $29
Should Harmony Biosciences’ Softer Q1 2026 Earnings and Upbeat Forecasts Require Action From HRMY Investors?
Harmony Biosciences Q1 Earnings Call Highlights
Sector Update: Health Care Stocks Softer Late Afternoon
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript